Pacific Edge has announced that Medicare coverage of Cxbladder tests in the US market is expected to cease from 17 July 2023, resulting in a substantial reduction in revenue.

The company is exploring legal options and cost containment initiatives while seeking to regain coverage.

A conference call will be held today to discuss the matter.

See more